Correlation between neonatal hyperbilirubinemia and vitamin D levels: A meta-analysis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 08 11 2020
accepted: 28 04 2021
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 21 10 2021
Statut: epublish

Résumé

Hyperbilirubinemia is a common disease in the neonatal period, and hyperbilirubinemia may cause brain damage. Therefore, prevention and diagnosis and management of hyperbilirubinemia is very important, and vitamin D may affect bilirubin levels. To evaluate the relationship between neonatal hyperbilirubinemia and vitamin D levels. The China National Knowledge Infrastructure, VIP, Wanfang, Chinese Biology Medicine Disc, PubMed, Web of Science, Cochrane Library, and Embase databases as well as clinical trial registries in China and the United States were searched for relevant studies from inception to September 2020 without restrictions on language, population, or year. The studies was screened by two reviewers independently, the data were extracted, and the risk of bias of the included studies was evaluated using the NOS. A meta-analysis was conducted on the included studies using Stata11 software. Six case-control studies were included, and the methodological quality of the studies was high (grade A). The studies included 690 newborns; more than 409 were diagnosed with hyperbilirubinemia. The means and standard deviations were calculated. Meta-analysis results showed that neonatal vitamin D levels were 7.1 ng/ml lower among infants with hyperbilirubinemia than among healthy newborn levels (z = 6.95, 95% CI 9.10 ~ 5.09, P < 0.05). Subgroup analysis was conducted based on whether the bilirubin levels were concentrated in the 15 to 20 mg/dl range. Vitamin D level of infants with hyperbilirubinemia (the bilirubin levels were concentrated in the 15 to 20 mg/dl range) was 9.52 ng/ml (Z = 15.55, 95% CI-10.72~-8.32, P<0.05) lower than that of healthy infants. The bilirubin levels in four cases were not concentrated in the 15-20 mg/dl range. The results showed that the vitamin D level of hyperbilirubinemia (The bilirubin levels were not concentrated in the 15-20 mg/dl range) neonates were 5.35 ng/ml lower than that of healthy neonates (Z = 6.43, 95% CI-6.98~-3.72, P<0.05). Vitamin D levels were observed to be lower in neonates with hyperbilirubinemia as compared to term neonates without hyperbilirubinemia in this study. This can possibly suggest that neonates with lower vitamin D levels are at higher risk for developing hyperbilirubinemia.

Identifiants

pubmed: 34043645
doi: 10.1371/journal.pone.0251584
pii: PONE-D-20-33494
pmc: PMC8158937
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Comparative Study Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0251584

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Ann Nutr Metab. 2018;73(2):145-159
pubmed: 30173219
Clin Exp Immunol. 2017 Sep;189(3):359-371
pubmed: 28470739
Int J Pediatr Adolesc Med. 2021 Mar;8(1):5-9
pubmed: 33718570
Pediatr Emerg Care. 2011 Sep;27(9):884-9
pubmed: 21926893
Iran J Child Neurol. 2020 Winter;14(1):7-19
pubmed: 32021624
Br J Hosp Med (Lond). 2017 Dec 2;78(12):699-704
pubmed: 29240507
Am J Clin Nutr. 2008 Aug;88(2):483S-490S
pubmed: 18689388
J Chin Med Assoc. 2016 Nov;79(11):614-617
pubmed: 27633666
J Fam Pract. 2019 Jan/Feb;68(1):E4-E11
pubmed: 30724909
Int Orthop. 2018 Sep;42(9):2273-2285
pubmed: 29504055
Pediatr Rev. 2006 Dec;27(12):443-54
pubmed: 17142466
BMC Pediatr. 2018 May 26;18(1):178
pubmed: 29803223
Clin Cases Miner Bone Metab. 2013 May;10(2):86-90
pubmed: 24133523
Iran J Public Health. 2016 May;45(5):558-68
pubmed: 27398328
J Ayurveda Integr Med. 2020 Apr - Jun;11(2):190-196
pubmed: 31628007

Auteurs

Jiayu Huang (J)

The First Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Qian Zhao (Q)

The First Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Jiao Li (J)

The First Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Jinfeng Meng (J)

The First Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Shangbin Li (S)

The First Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Weichen Yan (W)

The First Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Jie Wang (J)

The First Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Changjun Ren (C)

The First Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH